Cetuximab (review of TA176) and panitumumab (partial review of TA240) for the first line treatment of metastatic colorectal cancer [ID794]

Multiple Technology Appraisal (MTA)

Nicola Huxley, Louise Crathorne, Jo Varley-Campbell, Irina Tikhonova, Tristan Snowsill, Simon Briscoe, Jaime Peters, Mary Bond , Mark Napier, Martin Hoyle

Research output: Book/ReportCommissioned report

Original languageEnglish
PublisherUniversity of Exeter
Commissioning bodyNational Institute for Health and Care Excellence (NICE)
Number of pages24
Publication statusPublished - 2015
Externally publishedYes

Cite this